Corinne Atton practices complex patent litigation with a focus on pharmaceuticals, biologics, biotechnology, and medical devices. She has worked on cases concerning, among other things, DNA sequencing technologies, recombinant polypeptides, enzyme inhibitors, iron chelators, anti-diabetic drugs, wakefulness-promoting agents, surgical mesh affixing systems, and laser hair removal devices.
Corinne has represented clients at district court and appellate levels, and in inter partes review proceedings before the U.S. Patent Trial and Appeal Board.
She also has experience of patent due diligence associated with high profile acquisitions.
Corinne edits, writes for, and manages Venable's BiologicsHQ microsite - a website that provides statistical analyses and timely commentary concerning U.S. patent proceedings relating to FDA-approved biologic drugs.
Corinne formerly practiced as a barrister in the U.K., where she was involved in high value patent litigations, trademark litigations, and commercial litigations and arbitrations.